These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10795966)

  • 1. Adherence to HIV combination therapy.
    Chesney MA; Morin M; Sherr L
    Soc Sci Med; 2000 Jun; 50(11):1599-605. PubMed ID: 10795966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance, fitness, adherence, and potency: mapping the paths to virologic failure.
    Markowitz M
    JAMA; 2000 Jan; 283(2):250-1. PubMed ID: 10634342
    [No Abstract]   [Full Text] [Related]  

  • 4. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications.
    Miller LG; Hays RD
    AIDS Read; 2000 Mar; 10(3):177-85. PubMed ID: 10758022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helping the urban poor stay with antiretroviral HIV drug therapy.
    Bamberger JD; Unick J; Klein P; Fraser M; Chesney M; Katz MH
    Am J Public Health; 2000 May; 90(5):699-701. PubMed ID: 10800416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A review of socio-behavioural studies on adherence to antiretroviral treatments: beyond biomedical models?].
    Moatti JP; Spire B; Duran S
    Rev Epidemiol Sante Publique; 2000 Apr; 48(2):182-97. PubMed ID: 10804427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence and drug resistance: predictions for therapy outcome.
    Wahl LM; Nowak MA
    Proc Biol Sci; 2000 Apr; 267(1445):835-43. PubMed ID: 10819155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.
    Gifford AL; Bormann JE; Shively MJ; Wright BC; Richman DD; Bozzette SA
    J Acquir Immune Defic Syndr; 2000 Apr; 23(5):386-95. PubMed ID: 10866231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.
    Rutherford GW; Sangani PR; Kennedy GE
    Cochrane Database Syst Rev; 2003; (4):CD002037. PubMed ID: 14583945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health consequences of screening patients for adherence to highly active antiretroviral therapy.
    Tchetgen E; Kaplan EH; Friedland GH
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):118-29. PubMed ID: 11242178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.
    Eldred LJ; Wu AW; Chaisson RE; Moore RD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):117-25. PubMed ID: 9637576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring HIV treatment adherence in clinical practice.
    Hecht FM
    AIDS Clin Care; 1998 Aug; 10(8):57-9. PubMed ID: 11365682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonadherence raises concerns over resistance.
    AIDS Alert; 1998 Sep; 13(9):108. PubMed ID: 11365793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications.
    Friedman SR; Wainberg MA; Drucker E
    AIDS; 1998 Nov; 12(16):2089-93. PubMed ID: 9833849
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).
    Descamps D; Flandre P; Calvez V; Peytavin G; Meiffredy V; Collin G; Delaugerre C; Robert-Delmas S; Bazin B; Aboulker JP; Pialoux G; Raffi F; Brun-Vézinet F
    JAMA; 2000 Jan; 283(2):205-11. PubMed ID: 10634336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.